Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,000
Closed -$10.1K 3629
2022
Q1
$10.1K Sell
2,000
-100
-5% -$507 ﹤0.01% 2679
2021
Q4
$13.2K Buy
2,100
+2,000
+2,000% +$13.7K ﹤0.01% 2518
2021
Q3
$795 Hold
100
﹤0.01% 3337
2021
Q2
$749 Hold
100
﹤0.01% 3293
2021
Q1
$605 Sell
100
-600
-86% -$4.62K ﹤0.01% 3192
2020
Q4
$4K Buy
700
+400
+133% +$2.54K ﹤0.01% 2501
2020
Q3
$2K Buy
300
+200
+200% +$1.78K ﹤0.01% 2616
2020
Q2
$885 Sell
100
-900
-90% -$2.59K ﹤0.01% 2699
2020
Q1
$1.77K Buy
+1,000
New +$1.27K ﹤0.01% 2438

Other funds holding VXRT

American Portfolios Advisors's VXRT Position: Q2 2022 in Review

American Portfolios Advisors sold out of Vaxart (VXRT) in Q2 2022, closing a stake of 2,000 shares — an estimated $10.1K sold.

American Portfolios Advisors first reported a position in VXRT in Q1 2020 and held it in 9 quarters. The position peaked at $13.2K in Q4 2021. 146 funds tracked by Wall St. Rank hold VXRT as of Q2 2022.

  • American Portfolios Advisors reported no remaining Vaxart position as of Q2 2022 after selling out during the quarter.
  • American Portfolios Advisors sold 2,000 Vaxart shares in Q2 2022, an estimated $10.1K.
  • American Portfolios Advisors first reported a position in Vaxart in Q1 2020 and held it in 9 quarters.
  • American Portfolios Advisors's Vaxart position peaked at $13.2K in Q4 2021.
  • 146 funds tracked by Wall St. Rank held Vaxart as of Q2 2022.

Based on American Portfolios Advisors's 13F filing for Q2 2022, filed 20 Mar 2023.